Real-world effectiveness and safety of risankizumab in patients with plaque psoriasis in whom guselkumab failed recently: A multicenter retrospective study of switching within the interleukin-23 inhibitor class
oleh: Ahmed Bagit, BSc, Khalad Maliyar, MD, Jorge R. Georgakopoulos, MD, Brian Rankin, BSc, Alexander Rimke, MSc, Asfandyar Mufti, MD, Heather Le, CRC, Ronald Vender, MD, Vimal H. Prajapati, MD, Jensen Yeung, MD
| Format: | Article |
|---|---|
| Diterbitkan: | Elsevier 2023-09-01 |
Deskripsi
Subjek
biologic; efficacy; guselkumab; IL-23 inhibitor; psoriasis; risankizumab